Survey: Cancer Patients, Including New Yorkers, Increasingly Face COVID-19 Health Impact
A new survey shows that cancer patients are being impacted by COVID-19.
A new survey shows that cancer patients are being impacted by COVID-19.
Cancer patients and survivors are finding it increasingly challenging to get necessary health care as the COVID-19 pandemic persists. Many are experiencing financial stress and mental health issues as they try to navigate the difficult health and economic environment.
Untold insecurities weigh heavily on many Oklahomans, and on June 30, voters can ease some of that worry by voting ‘yes’ on State Question 802.
On the day before New York State's flavored e-cigerette law takes affect, public health and social justice organizations ask for the sale of all menthol tobacco roducts to also be prohibited.
The American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, the Campaign for Tobacco-Free Kids, and the Preventing Tobacco Addiction Foundation released the following statement after the Legislature voted Friday to put sweeping changes to the Tobacco Settlement Endowment Trust on the November ballot.
Today the U.S. House of Representatives will vote on the Heroes Act, a package of legislative proposals aimed at addressing numerous pandemic-related health, research and economic relief needs. Included in the bill are several provisions that would make it easier for Americans to maintain or gain health insurance coverage.
COLUMBUS, OH – The unpredictable and dynamic nature of COVID-19 is no match for the steadfast commitment of the American Cancer Society Cancer Action Network’s (ACS CAN) volunteers.
Twenty patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae (“friend-of-the-court”) brief today with the U.S. Supreme Court in the case California v. Texas (previously Texas v. United States), citing the devastating impact patients would face should the court rule to invalidate the Affordable Care Act (ACA).
he Centers for Medicare and Medicaid Services (CMS) recently issued a proposed rule detailing how the government would cover costs for Chimeric antigen receptor (CAR) T-cell cancer therapy for Medicare enrollees.
The Department of Health and Human Services (HHS) this week finalized the 2021 Notice of Benefit and Payment Parameters, which sets the rules for health care plans in the coming year.